Himed and Lithoz launch Bioceramics Center of Excellence for medical device manufacturers
Himed, based in New York, USA, and Lithoz, Vienna, Austria, have announced the launch of a new Bioceramics Center of Excellence (BCoE) at Himed’s New York headquarters. The BCoE looks to offer a holistic approach to R&D with bioceramics for medical device manufacturers by integrating various analytical services to support the rapid prototyping process.
The newly founded centre will unite Himed’s three decades of experience of working with bioceramics for efficient human bone healing with the design freedom offered by Lithoz’s ceramic LCM technology, a form of Vat Photopolymerisation Additive Manufacturing. It will provide a comprehensive suite of services, including design support and optimisation, SEM imaging, material analysis and characterisation, biomaterial customisation, and bioceramic Additive Manufacturing using a Lithoz CeraFab S65 Medical AM machine.
TRUSTED BY INDUSTRY’S BIGGEST NAMES
Discover how we help leading brands shape the industry conversation
| Contact us |
“Lithoz’s technology is unlike anything else out there — they’ve solved some meaningful challenges in this field, and their printers can take you from concept all the way through production. That’s going to open up new avenues for invention in implant design,” says Dana Barnard, CEO of Himed.
The company aims to promote the development of innovative manufacturing processes for bioceramic materials and help customers explore new compositions and manufacturing techniques that may have previously been out of reach for some companies. The BCoE will particularly benefit medtech startups and other businesses looking to cost-effectively prototype and optimise designs using bioceramics.
“Before investing in a medical 3D printer companies can effectively lease time on one, along with the support and materials expertise of Himed’s engineers and scientists supporting them from concept through optimisation,” explained Himed President Craig Rosenblum.
The news follows the strategic partnership announced last year between Lithoz and Himed. The partnership outlined plans for an R&D collaboration to design new slurries for use in Lithoz’s ceramic medical-grade Additive Manufacturing machines.
Dr Johannes Homa, CEO of Lithoz, said, “This new Bioceramics Center of Excellence will open up a new chapter in 3D-printed medical applications for North America! We are excited to be the technology partner enabling Himed’s bioceramic innovation – with the combination of Himed’s experience and Lithoz technology, new applications will certainly be enabled which are currently unthinkable.”
